Free Trial

TerrAscend 8/8/2024 Earnings Report

TerrAscend logo
$0.53 -0.01 (-2.58%)
As of 02/21/2025 03:51 PM Eastern

TerrAscend EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.02
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$77.52 million
Expected Revenue
$80.70 million
Beat/Miss
Missed by -$3.18 million
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Time
After Market Closes

Conference Call Resources

TerrAscend Earnings Headlines

TerrAscend reports preliminary Q4 revenue $74.4M vs. $74.2M last quarter
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat